New england journal of medicine publishes positive initial regeneron antibody cocktail results in non-hospitalized patients with covid-19

Tarrytown, n.y., dec. 17, 2020 /prnewswire/ -- regeneron pharmaceuticals, inc. (nasdaq: regn) today announced that the new england journal of medicine (nejm) has published initial clinical data from an ongoing seamless phase 1/2/3 trial of the antibody cocktail casirivimab and imdevimab...
REGN Ratings Summary
REGN Quant Ranking